DFS vs IMCR
DFS (DFS) versus Immunocore Holdings Ltd (IMCR) — a side-by-side from cached financials, not a winner call.
DFS (DFS) common stock.
Immunocore Holdings Ltd (IMCR) is a biotechnology company listed on NASDAQ.
DFS does not have a complete income-statement cache yet.
Latest reported IMCR revenue for 2026-06-30 was $222.6M. Net income was $12.2M. IMCR currently screens at market cap $1.45B.
IMCR currently screens at market cap $1.45B.
Not investment advice. Open the DFS and IMCR stock pages for the full models.
Not investment advice.